Serum Institute produces AstraZeneca's Covid-19 vaccine under the brand name Covishield. The vaccine is one of India's two main vaccines against Covid pandemic under mass vaccination drive.
While the AstraZeneca vaccine produced in Europe, branded Vaxzevira, has been greenlighted by the European Medicines Agency (EMA), the Indian version Covishield has not even requested for market authorization.
India's Serum Institute is seeking emergency authorisation in the European Union for its Covishield jab, the BBC reported.
When political jabbing over Covaxin jabs and bar on foreign travel has not subsided, the EU's vaccine passport from July 1 even bars Covishield vaccinated. USA has no such plans, but not vaccinated with FDA approved ones then some restrictions apply
Bhubaneswar: In order to ramp up the vaccination drive in the State, Odisha government on Thursday said that people interested to inoculate themselves against Covid-19 at private hospitals can do…
Bhubaneswar: Odisha is all set to receive a fresh lot of one lakh doses of Covishield vaccines today. “So far, 55,50,380 doses of Covid-19 vaccines have been administered. Western Odisha…
Bhubaneswar: The Odisha government has decided to extend the interval between two doses of Covishield vaccine from the existing four to six weeks time to four to eight weeks in the State. The decision follows a recommendation from the National Technical Advisory Group on Immunization (NTAGI) and National Expert Group on Vaccine Administration for Covid-19 […]
Colombo: Sri Lankan President Gotabaya Rajapaksa on Thursday thanked India for its generosity after he received 500,000 doses of Covishield vaccine donated by the country under the ‘Neighbourhood First’ policy. India last week announced that it will send COVID-19 vaccines under grant assistance to Sri Lanka and seven other countries — Bhutan, the Maldives, Bangladesh, […]
Bhubaneswar: Ahead of the mass inoculation drive across the country, the State Health and Family Welfare Department on Wednesday issued guidelines with regard to Covid-19 vaccination to be carried out from January 16 at around 160 sessions in different districts and Municipal Corporations in Odisha. The State has received 4.08 lakh doses of Covishield vaccine […]
New Delhi: The government on Monday placed a purchase order for 11 million doses of Oxford COVID-19 vaccine- Covishield, with Serum Institute of India (SII), each costing Rs 210, including the GST. Dispatch of the vaccine is likely to start by late Monday evening, officials informed. According to the order, each dose of the vaccine […]
Bhubaneswar: With the Union Health Ministry giving the green signal to roll out Covid-19 vaccines across the country from coming Makar Sankrati, Odisha will also see the first dispatch of vaccines reaching the State by January 13-14. Even though Odisha had conducted the dry run for Covid-19 vaccines in all districts on January 2, the […]
New Delhi: Serum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 vaccine, Covishield. “As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine, COVISHIELD. This will save countless lives, and I thank the Government of India and […]
New Delhi: The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two weeks. Adar Poonawalla, Founder and CEO, SII said on Saturday that SII is in the process of submitting the data for the clinical trials to the DCGI and will seek emergency use authorisation. […]